- Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
- GeneType to Enter Canadian and New Zealand Markets
- GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
- Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
- Genetic Technologies Expands Operational Capacity in North America
- GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
- GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
- GeneType and Humanise Health host “Know Your Risk” Event
- GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
- Appendix 4C & Quarterly Business Update – March 2024
More ▼
Key statistics
On Friday, Genetic Technologies Ltd (GENE:NAQ) closed at 0.852, 13.60% above the 52 week low of 0.75 set on Jul 12, 2024.
52-week range
Open | 0.787 |
---|---|
High | 0.883 |
Low | 0.77 |
Bid | 0.85 |
Offer | 0.8845 |
Previous close | 0.7851 |
Average volume | 57.49k |
---|---|
Shares outstanding | 4.85m |
Free float | 1.17m |
P/E (TTM) | -- |
Market cap | 4.18m USD |
EPS (TTM) | -1.15 USD |
Data delayed at least 15 minutes, as of Jul 26 2024 20:58 BST.
More ▼